Volume 21, Issue 10, Pages (December 2017)

Slides:



Advertisements
Similar presentations
Volume 46, Issue 5, Pages e3 (May 2017)
Advertisements

Volume 156, Issue 4, Pages (February 2014)
Volume 8, Issue 12, Pages (December 2000)
Volume 23, Issue 9, Pages (May 2018)
Peter D. Kwong, John R. Mascola  Immunity 
Volume 24, Issue 5, Pages (May 2016)
Volume 43, Issue 5, Pages (November 2015)
Volume 23, Issue 6, Pages (May 2018)
Accurate design of megadalton-scale two-component icosahedral protein complexes by Jacob B. Bale, Shane Gonen, Yuxi Liu, William Sheffler, Daniel Ellis,
Volume 125, Issue 1, Pages (April 2006)
Volume 37, Issue 5, Pages (March 2010)
Volume 11, Issue 10, Pages (June 2015)
Volume 22, Issue 7, Pages (February 2018)
Chen-Chou Wu, William J. Rice, David L. Stokes  Structure 
Volume 35, Issue 5, Pages (November 2011)
Volume 18, Issue 12, Pages (December 2010)
Volume 5, Issue 5, Pages (December 2013)
Structural Basis for Regulation of ESCRT-III Complexes by Lgd
Volume 3, Issue 5, Pages (May 2013)
Erik Procko, Ian Ferrin-O'Connell, Sze-Ling Ng, Rachelle Gaudet 
Volume 43, Issue 6, Pages (December 2015)
Volume 139, Issue 6, Pages (December 2009)
Coiled Coils Direct Assembly of a Cold-Activated TRP Channel
Volume 40, Issue 6, Pages (December 2010)
Volume 23, Issue 2, Pages (April 2018)
Young Jun Im, James H. Hurley  Developmental Cell 
Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield  Thomas.
Volume 21, Issue 6, Pages (June 2013)
Selective Dimerization of a C2H2 Zinc Finger Subfamily
Volume 128, Issue 3, Pages (February 2007)
Alexander Falkenhagen, Sadhna Joshi  Molecular Therapy - Nucleic Acids 
Volume 20, Issue 1, Pages 9-19 (October 2005)
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
Volume 23, Issue 1, Pages (April 2018)
Volume 38, Issue 5, Pages (June 2010)
Volume 21, Issue 1, Pages (October 2017)
Volume 22, Issue 12, Pages (December 2014)
Structural Analysis Uncovers Lipid-Binding Properties of Notch Ligands
Structure of the Catalytic Region of DNA Ligase IV in Complex with an Artemis Fragment Sheds Light on Double-Strand Break Repair  Takashi Ochi, Xiaolong.
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Daniel Olal, Oliver Daumke  Cell Reports 
Volume 21, Issue 9, Pages (September 2013)
Volume 23, Issue 6, Pages (May 2018)
Volume 23, Issue 3, Pages (April 2018)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Coiled-Coil Domains of SUN Proteins as Intrinsic Dynamic Regulators
Volume 23, Issue 4, Pages (April 2015)
Volume 14, Issue 4, Pages (April 2006)
Volume 23, Issue 12, Pages (December 2015)
Shiqian Qi, Do Jin Kim, Goran Stjepanovic, James H. Hurley  Structure 
Volume 14, Issue 9, Pages (March 2016)
Volume 24, Issue 8, Pages (August 2016)
Volume 19, Issue 2, Pages (April 2017)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
A Stable Prefusion Intermediate of the Alphavirus Fusion Protein Reveals Critical Features of Class II Membrane Fusion  Claudia Sánchez-San Martín, Hernando.
Volume 87, Issue 3, Pages (November 1996)
Volume 7, Issue 3, Pages (May 2014)
Volume 1, Issue 1, Pages (January 2008)
Volume 49, Issue 2, Pages e8 (August 2018)
Volume 153, Issue 7, Pages (June 2013)
Structural and Mechanistic Analysis of the Slx1-Slx4 Endonuclease
Dicer-like Enzymes with Sequence Cleavage Preferences
Volume 25, Issue 6, Pages e5 (June 2019)
Volume 17, Issue 6, Pages (November 2016)
Volume 27, Issue 23, Pages e6 (December 2017)
Volume 114, Issue 2, Pages (July 2003)
Sabine Pokutta, William I. Weis  Molecular Cell 
Volume 49, Issue 6, Pages e8 (December 2018)
Volume 21, Issue 1, Pages (October 2017)
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Presentation transcript:

Volume 21, Issue 10, Pages 2992-3002 (December 2017) Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains  M. Gordon Joyce, Ivelin S. Georgiev, Yongping Yang, Aliaksandr Druz, Hui Geng, Gwo-Yu Chuang, Young Do Kwon, Marie Pancera, Reda Rawi, Mallika Sastry, Guillaume B.E. Stewart-Jones, Angela Zheng, Tongqing Zhou, Misook Choe, Joseph G. Van Galen, Rita E. Chen, Christopher R. Lees, Sandeep Narpala, Michael Chambers, Yaroslav Tsybovsky, Ulrich Baxa, Adrian B. McDermott, John R. Mascola, Peter D. Kwong  Cell Reports  Volume 21, Issue 10, Pages 2992-3002 (December 2017) DOI: 10.1016/j.celrep.2017.11.016 Copyright © 2017 Terms and Conditions

Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 1 Design of Chimeric gp120 BG505 DS-SOSIP HIV-1-Env Trimers (A) Ribbon diagram of BG505.SOSIP-Env trimer in its closed prefusion state with gp120 subunit in light blue and gp41 subunit in light red, with inset of the gp41 wrapping around the N and C termini of gp120. (B) Surface representation of HIV-1-Env in its closed prefusion state with gp120 in light blue and gp41 in salmon. (C) Schematic of gp120 and gp41 sequences with SOS, I559P, and DS mutations, along with a second schematic of a gp120 chimera with non-BG505 region colored in purple. (D) Surface representation of gp120 chimera SOSIP.DS molecules with purple for other gp120 strains, salmon for BG505.SOSIP.664 gp41, and light blue for BG505 gp120 region. (E) Surface representation of gp120 chimera for SC422.8 clade B Env (left) and ZM106.9 clade C Env (right). See also Figure S1 and Table S1. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 2 Antigenic Selection of Prefusion Closed HIV-1-Env Trimers with DS-SOSIP or BG505 DS-SOSIP Chimera Design (A) Schematic of the high-throughput 96-well expression-antigenic screening system. (B) Antibodies used in antigenic selection, rationale for use, and antibody neutralization breadth on the 180-isolate panel. (C) HIV-Env trimer-binding responses relative to BG505 DS-SOSIP. The values displayed at the top of the graph indicates the number of Env molecules with binding response at least 75% that of BG505 DS-SOSIP Env. Dotted line indicates 75% binding response relative to BG505 DS-SOSIP. See also Tables S2–S4 and Figures S4 and S5. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 3 Properties of DS-SOSIP.664 from Clade C Strain ZM106.9 (A) Gel filtration profile for chimeric ZM106.9 DS-SOSIP.664 obtained following GNA-lectin affinity chromatography. (B) SDS-PAGE analysis of purified chimeric ZM106.9 DS-SOSIP. A diffuse band corresponding to glycosylated gp41 can be seen under reducing conditions. M, markers; 1, ZM106.9 chimeric DS-SOSIP.664 under non-reducing conditions; 2, ZM106.9 chimeric DS-SOSIP.664 under reducing conditions. (C) Antigenic analysis of ZM106.9 DS-SOSIP.664 following 447-52D negative selection (data shown are the mean of two independent assays). See also Table S3. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 4 Properties of DS-SOSIP.664 Chimera from Clade C Strain 3301.V1.C24 (A) Gel filtration profile for chimeric 3301.V1.C24 DS-SOSIP.664 chimera obtained from lectin affinity chromatography. (B) SDS-PAGE analysis of purified 3301.V1.C24 DS-SOSIP chimera. A somewhat diffuse band corresponding to glycosylated gp41 can be seen under reducing conditions. M, markers; 1, 3301.V1.C24 DS-SOSIP.664 chimera under non-reducing conditions; 2, 3301.V1.C24 DS-SOSIP.664 chimera under reducing conditions. (C) Antigenic analysis of 3301.V1.C24 DS-SOSIP.664 chimera following 447-52D negative selection (data shown are the mean of two independent assays). See also Table S3. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 5 Properties of DS-SOSIP.664 from Clade C Strain 25925.22 (A) Gel filtration profile for chimeric 25925.2.22 DS-SOSIP.664 chimera obtained from lectin affinity chromatography. (B) SDS-PAGE analysis of purified chimeric 25925.2.22 DS-SOSIP. A diffuse band corresponding to glycosylated gp41 can be seen under reducing conditions. M, markers; 1, 25925.22 DS-SOSIP.664 chimera under non-reducing conditions; 2, 25925.2.22 DS-SOSIP.664 chimera under reducing conditions. (C) Antigenic analysis of 25925.2.22 DS-SOSIP.664 chimera following 447-52D negative selection (data shown are the mean of two independent assays). See also Table S3. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 6 Negative-Stain EM of Selected DS-SOSIP.664 Chimera Env Trimer Molecules EM analysis was performed on proteins after lectin affinity and size exclusion chromatography. Shown are images of class averages for five of the chimeric gp140 constructs from different HIV-1 strains. The scale bar represents 5 nm. See also Figure S3. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions

Figure 7 HIV-1 Strains that Form Closed Prefusion Molecules in Either the SOSIP or DS-SOSIP Chimera Designs (A) HIV-1-Env molecules from different strains that could form closed prefusion Env trimer molecules are displayed on a representative HIV-1 phylogenetic tree constructed using global isolate sequences of HIV-1. (B) A set of 19 HIV-1 strains from different clades was also assessed for alternate design strategies, including incorporation of additional interface residues (46–54, 70–75, 84–89, 99, 102, 106, 107, 114, 215, 220–224, 226, 244, 471–473, and 476–477) from BG505.SOSIP (DS-SOSIP chimera-Int), as well as use of a 15-amino acid linker region combined with the DS-SOSIP chimera design (DS-SOSIP chimera.sc15ln). Dotted line indicates 75% binding response relative to BG505 DS-SOSIP. See also Tables S1, S3, and S4. Cell Reports 2017 21, 2992-3002DOI: (10.1016/j.celrep.2017.11.016) Copyright © 2017 Terms and Conditions